查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886309

移植用HLA分型市場－全球產業規模、佔有率、趨勢、機會及預測，依產品及服務、技術、應用、移植類型、地區及競爭格局分類，2020-2030年預測

HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service, By Technology, By Application, By Transplant Type Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球移植用HLA分型市場規模為19.2億美元，預計2030年將以6.91%的複合年成長率成長至28.7億美元。移植以人類白血球抗原（HLA）分型是一種分子診斷過程，透過識別特定的HLA基因和蛋白質來確定器官和幹細胞供體與受體之間的相容性，從而最大限度地減少免疫排斥反應並提高移植成功率。

市場概覽
預測期 2026-2030
市場規模：2024年 19.2億美元
市場規模：2030年 28.7億美元
複合年成長率：2025-2030年 6.91%
成長最快的細分市場 試劑和耗材
最大的市場 北美洲

主要市場促進因素

全球對器官和幹細胞移植的需求不斷成長，顯著推動了人類白血球抗原（HLA）分型市場的發展。末期腎病、肝衰竭和各種血液系統惡性腫瘤等慢性疾病的日益普遍，使得這些挽救生命的治療手段變得尤為重要。

主要市場挑戰

全球範圍內持續存在的相容性供體器官短缺嚴重阻礙了全球人類白血球抗原（HLA）分型移植市場的擴張。 HLA分型的基礎需求與移植手術的數量密切相關，因為這些診斷檢測對於評估捐贈者與受體的相容性以及降低免疫排斥反應至關重要。

主要市場趨勢

人工智慧在人類白血球抗原（HLA）資料分析中的應用日益廣泛，提高了移植供體-受體匹配的精確度。人工智慧演算法能夠高效處理海量基因組資料，實現複雜的模式識別和預測建模，這對於應對HLA基因複雜的遺傳多態性至關重要。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球HLA分型移植市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品和服務分類（試劑和耗材、儀器、軟體和服務）
    • 依技術分類（分子檢測技術、非分子檢測技術）
    • 依應用領域（診斷應用、抗體篩檢、嵌合體監測、研究應用、其他）
    • 依移植類型（實體器官移植、軟組織移植）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美HLA分型移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲HLA分型在移植的應用市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區HLA分型在移植的應用市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲HLA分型在移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲HLA分型移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球移植用HLA分型市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Qiagen NV
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Immucor, Inc.
  • Caredx. Inc.
  • Luminex Corporation (Diasorin)
  • Tbg Diagnostics Limited

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22275

The Global HLA Typing for Transplant Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.91% to reach USD 2.87 Billion by 2030. Human Leukocyte Antigen (HLA) typing for transplant is a molecular diagnostic process identifying specific HLA genes and proteins to determine compatibility between organ and stem cell donors and recipients, thereby minimizing immune rejection and enhancing transplant success.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.92 Billion
Market Size 2030USD 2.87 Billion
CAGR 2025-20306.91%
Fastest Growing SegmentReagents & Consumables
Largest MarketNorth America

Key Market Drivers

The escalating global demand for organ and stem cell transplants significantly propels the Human Leukocyte Antigen typing market. The rising prevalence of chronic diseases like end-stage renal disease, liver failure, and various hematologic malignancies necessitates these life-saving procedures. This increasing demand directly translates into a greater need for precise HLA compatibility assessment to ensure successful engraftment and minimize rejection rates.

Key Market Challenges

The persistent global shortage of compatible donor organs significantly impedes the expansion of the Global Human Leukocyte Antigen typing for transplant market. The foundational demand for HLA typing is intrinsically linked to the volume of transplant procedures performed, as these diagnostic tests are essential for assessing donor-recipient compatibility and mitigating immune rejection. A scarcity of available organs directly limits the number of potential transplant surgeries, thereby reducing the overall requirement for HLA typing.

Key Market Trends

The increasing application of Artificial Intelligence in Human Leukocyte Antigen data analysis is enhancing the precision of donor-recipient matching for transplantation. AI algorithms efficiently process extensive genomic data, enabling sophisticated pattern recognition and predictive modeling essential for navigating the complex polymorphism of HLA genes. This capability directly improves transplant success rates by identifying optimal matches and mitigating immune complications.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Immucor, Inc.
  • Caredx. Inc.
  • Luminex Corporation (Diasorin)
  • Tbg Diagnostics Limited

Report Scope:

In this report, the Global HLA Typing for Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

HLA Typing for Transplant Market, By Product & Service:

  • Reagents & Consumables
  • Instruments
  • Software & Services

HLA Typing for Transplant Market, By Technology:

  • Molecular Assay Technologies
  • Non-molecular Assay Technologies

HLA Typing for Transplant Market, By Application:

  • Diagnostic Applications
  • Antibody Screening
  • Chimerism Monitoring
  • Research Applications
  • Others

HLA Typing for Transplant Market, By Transplant Type:

  • Solid Organ Transplant
  • Soft Tissue Transplant

HLA Typing for Transplant Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global HLA Typing for Transplant Market.

Available Customizations:

Global HLA Typing for Transplant Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global HLA Typing for Transplant Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Service (Reagents & Consumables, Instruments, Software & Services)
    • 5.2.2. By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies)
    • 5.2.3. By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others)
    • 5.2.4. By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America HLA Typing for Transplant Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Transplant Type
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States HLA Typing for Transplant Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Service
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Transplant Type
    • 6.3.2. Canada HLA Typing for Transplant Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Service
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Transplant Type
    • 6.3.3. Mexico HLA Typing for Transplant Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Service
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Transplant Type

7. Europe HLA Typing for Transplant Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Service
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Transplant Type
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany HLA Typing for Transplant Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Service
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Transplant Type
    • 7.3.2. France HLA Typing for Transplant Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Service
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Transplant Type
    • 7.3.3. United Kingdom HLA Typing for Transplant Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Service
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Transplant Type
    • 7.3.4. Italy HLA Typing for Transplant Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Service
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Transplant Type
    • 7.3.5. Spain HLA Typing for Transplant Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Service
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Transplant Type

8. Asia Pacific HLA Typing for Transplant Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Service
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Transplant Type
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China HLA Typing for Transplant Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Service
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Transplant Type
    • 8.3.2. India HLA Typing for Transplant Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Service
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Transplant Type
    • 8.3.3. Japan HLA Typing for Transplant Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Service
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Transplant Type
    • 8.3.4. South Korea HLA Typing for Transplant Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Service
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Transplant Type
    • 8.3.5. Australia HLA Typing for Transplant Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Service
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Transplant Type

9. Middle East & Africa HLA Typing for Transplant Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Service
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Transplant Type
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia HLA Typing for Transplant Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Service
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Transplant Type
    • 9.3.2. UAE HLA Typing for Transplant Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Service
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Transplant Type
    • 9.3.3. South Africa HLA Typing for Transplant Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Service
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Transplant Type

10. South America HLA Typing for Transplant Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Service
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By Transplant Type
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil HLA Typing for Transplant Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Service
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Transplant Type
    • 10.3.2. Colombia HLA Typing for Transplant Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Service
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Transplant Type
    • 10.3.3. Argentina HLA Typing for Transplant Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Service
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Transplant Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global HLA Typing for Transplant Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Illumina, Inc.
  • 15.3. Qiagen N.V.
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. F. Hoffmann-La Roche Ltd
  • 15.6. Immucor, Inc.
  • 15.7. Caredx. Inc.
  • 15.8. Luminex Corporation (Diasorin)
  • 15.9. Tbg Diagnostics Limited

16. Strategic Recommendations

17. About Us & Disclaimer